The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Today’s RNS, once again, underpins my argument that Redx is spectacularly undervalued, and is being actively chased, at these ‘fire sale’ prices, by both institutional and shrewd private investors who recognise the material opportunity on show. And the window for taking advantage of a share price sub 15p (an absolute steal) is closing fast.
And in case you didn’t notice, the London market appears to be entering into a 'new normal’ with delisting companies’ valuation staging a strong recovery back to their pre-announcement levels as investors slowly begin to realise that, the UK markets are not just illiquid, they’re completely broken and closed, and that they are actually better off diversifying (listed and unlisted) their equity investments for maximum capital growth.
Or put another way, the lack of interest in UK equities, that has seen 34 months of net outflows and left the UK the cheapest major market in the world on a PE basis, is triggering a significant step change in the way private investors view unlisted equities. The latter simply offer a substantially better return on investment, where companies like Redx can access a broader universe of specialty investors and, accordingly, a larger quantum of future funding required to execute their strategy. So why should they jump the financial and regulatory hurdles of public market life when growth capital can be easily found elsewhere?
From my viewpoint, and having been invested in Redx for the last 18 months, I strongly believe this is an incredible opportunity to buy into a remarkable business at bargain-basement prices. Period.
The company has an impressive track record of executing sale/licensing deals with attractive economics, especially given the early, research/preclinical stage of development, has provided external validation of Redx’s medicinal chemistry expertise and drug design capabilities.
Importantly, these deals have facilitated continued pipeline progress and provided non-dilutive funding to support the wholly-owned priority ROCK portfolio.
Specifically, and following the February 2024 KRAS licensing deal, Redx now has four partnership agreements: three with Jazz and one with AstraZeneca.
And to date, upfront/milestone receipts total £51.5m, with potential future success-based milestones of circa £1.3bn in aggregate plus royalties on sales.
Two words: Spectacularly Undervalued
.
CEO Lisa buys 399,000 Shares but it's only £30k.. not exactly breaking the bank is it. Just pocket change relative to her compensation and net worth. In total only owns a fraction, "Following this, Lisa Anson will hold 562,183 ordinary shares in the Company, representing 0.14 per cent. of the issued share capital."
We should have taken this share price to over 50p and then let them buy at that price.
Rns out. Director buying. This shows how corrupt. Delisting then buying the shares on the cheap instead of buying at over 30p. Really fleeced the peeps. This is not right.
Zzzzz 😴 💤 🛏 🤡 🤡
Will it pop tomorrow 10p maybe at least 9p minimum.
Let’s see the value tomorrow.
I respect your opinion.
Let’s bring that matter a close.
We will see what happens in the next couple of weeks.
Lol, freedom of speech is fine, but what's BOOM! POP! Sky Rocket got to do with Redx or any other share, it's just silly boys ramping nonsense.
I respect that…But if it is someone’s opinion it is there right to say what they think or feel , Likewise it is your opinion but with the greatest of respect to you we live in a world of freedom of speech and we can say BOOM! POP!Sky Rocket and another phrase we so wish.
You first, I'm fed up with phrases like BOOM, POP, about to sky rocket etc from ramping day traders .... now grow up.
You seem to want to wind people up on here do you have some issues if so try to keep calm and respectful and if it’s all to much for you I would strongly suggest you give this chat forum break.
It's not advice, if you read it correctly it's just my personal opinion clever Alec 😉
Thank you for the advice, I will do what have said thank you for your assistance.
I don't think it will get above 9p before delisting, maybe you'd better keep your finger on the sell but if you're day trading 🤔? JMO Adyor!
I think you not right on that consensus, it’s not going to rocket but it will go higher than it is at present that’s what I am saying.
10p is a safe figure I would say.
No it isn't, nothing will happen until it delists at the end of April, you'll just have to sit tight like the rest of us..
God help us moniman you are so negative .this is heading up.
It's not 2pm yet. Hold your horses.
No BooM for you day traders today I'm afraid, you'll just have to be patient and wait for the delisting on 30th April like the rest of us. Only then will the true value of Redx be realised once off AIM.
Yes I have noticed that also once we hit 2pm we see activity.
Does seem like the institution buying, or their broker, does wake up until 2pm.
Could we get to 10p today a very good chance.
Looks like we are going in the right direction.
Let’s see how we go through the day very undervalued as it stands at present,
I think 12p is around the value we will be at by tomorrow my opinion before I get slated for my views.
Wow, current mcap is about a tenth of that.
Proven track record of developing novel molecules with one already approved and bought. Trading at about the value of their cash on hand. Despite several molecules in development and billions in potential contracts. Most recent broker target was over £300 million. The potential is clear and we have someone buying up millions of shares in a go down here. Looks promising to me.
Who knows?